Exelixis (EXEL) Change in Account Payables (2016 - 2026)

Exelixis (EXEL) recorded quarterly Change in Account Payables of -$17.9 million in Q2 2026, down 38.74% quarter-over-quarter from -$12.9 million in Q1 2026, and down 310.53% on a YoY basis from $8.5 million in Q2 2025.

Exelixis (EXEL) Change in Account Payables (2016 - 2026) Analysis & Trends

Exelixis' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$17.9 million for Q2 2026.

  • In Q2 2026, Change in Account Payables fell 310.53% year-over-year to -$17.9 million; the TTM figure through Apr 2026 stood at -$76.6 million (down 466.94% YoY), while the FY2026 annual figure was -$50.2 million, down 129.15% from the prior year.
  • Change in Account Payables was -$17.9 million for Q2 2026 at Exelixis, down from -$12.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $43.6 million in Q4 2023 to a low of -$63.5 million in Q3 2025.
  • Historically, Change in Account Payables has averaged -$968823.5 across 5 years, with a median of $2.2 million in 2025.
  • Biggest YoY gain for Change in Account Payables was 3481.14% in 2024; the steepest drop was 8332.45% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $19.8 million in 2022, then jumped by 120.68% to $43.6 million in 2023, then plunged by 39.52% to $26.4 million in 2024, then tumbled by 32.73% to $17.8 million in 2025, then tumbled by 200.8% to -$17.9 million in 2026.
  • The last three Change in Account Payables figures came in at -$17.9 million (Q2 2026), -$12.9 million (Q1 2026), and $17.8 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -3.26 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 35.60 Mn
9 Abivax 95.45 Bn 95.45 Bn - -9.42 Mn
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn -17.90 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -17.90 Mn
Apr 3, 2026 -17.90 Mn
Jan 2, 2026 -12.90 Mn
Jan 2, 2026 -12.90 Mn
Oct 3, 2025 17.76 Mn
Oct 3, 2025 17.76 Mn
Jul 4, 2025 -63.51 Mn
Jul 4, 2025 -63.51 Mn
Apr 4, 2025 8.50 Mn
Apr 4, 2025 8.50 Mn
Jan 3, 2025 2.24 Mn
Jan 3, 2025 2.24 Mn
Sep 27, 2024 26.39 Mn
Sep 27, 2024 26.39 Mn
Jun 28, 2024 -16.28 Mn
Jun 28, 2024 -16.28 Mn
Mar 29, 2024 -34.25 Mn
Mar 29, 2024 -34.25 Mn
Dec 29, 2023 43.64 Mn
Dec 29, 2023 43.64 Mn